Sodium glucose co-transporter inhibitors and methods of their use
US9365602B2 · kind B2 · utility
0Cited by
13References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 25, 2013 |
| Grant date | Jun 14, 2016 |
| Priority date | — |
| Expiry date | Aug 23, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H15/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Sulfanyl-tetrahydropyran-based compounds, pharmaceutical compositions comprising them, and methods of their use for the treatment of diseases and disorders such as diabetes and obesity are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.